Dmitry Gabrilovich
Dmitry Gabrilovich | |
|---|---|
| [[File:|frameless|upright=1]] Gabrilovich in the lab | |
| Born | Birth date -1st March 1966 |
| Occupation | Researcher, professor |
| Years active | 1984–present |
Dmitry Gabrilovich, M.D., Ph.D., is a researcher and Christopher M. Davis professor at The Wistar Institute in Philadelphia.[1][2] His laboratory at Wistar focuses on methods by which tumors are able to suppress the immune system and how to develop new immune therapies to combat this ability.
The Gabrilovich lab focuses on immature myeloid cell biology and its relation to cancer. These cells have been linked to a number of signaling pathways associated with cancer, including NF-κB, Jak-STAT, Notch, Wnt, and Rb, among others.[3][4] His research has found that tumor cells can go through a mechanism that produces a free radical peroxynitrite, causing them to become resistant to certain types of cancer immunotherapy.[5] His research has also focused on monocytic-myeloid derived suppressor cells and polymorphonuclear-myeloid derived suppressor cells and what impact they might have on cancer therapy, since myeloid derived suppressor cells negatively regulate anti-tumor activity.[6]
Prior to joining The Wistar Institute, Gabrilovich was a senior member at the Moffitt Cancer Center in Tampa.[7]
Select publications[edit | edit source]
- Condamine T, Ramachandran I, Youn JI, Gabrilovich DI. Regulation of tumor metastasis by myeloid-derived suppressor cells. Annu Rev Med. 2015 Jan 14;66:97-110.
- Nagaraj S, Youn JI, Gabrilovich DI. Reciprocal Relationship between Myeloid-Derived Suppressor Cells and T Cells. J Immunol. 2013 Jul 1;191(1):17-23.
- Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer. 2013 Oct;13(10):739-52.
- Youn JI, Kumar V, Collazo M, Nefedova Y, Condamine T, Cheng P, Villagra A, Antonia S, McCaffrey JC, Fishman M, Sarnaik A, Horna P, Sotomayor E, Gabrilovich DI. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat Immunol. 2013 Mar;14(3):211-20.
- Condamine T, Kumar V, Ramachandran IR, Youn JI, Celis E, Finnberg N, El-Deiry WS, Winograd R, Vonderheide RH, English NR, Knight SC, Yagita H, McCaffrey JC, Antonia S, Hockstein N, Witt R, Masters G, Bauer T, Gabrilovich DI. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. J Clin Invest. 2014 Jun 2;124(6):2626-39
References[edit | edit source]
- ↑ "Dmitry I. Gabrilovich, M.D., Ph.D." The Wistar Institute. Retrieved 17 February 2014.
- ↑ "Prof Dmitry Gabrilovich". Cancer Vaccine Institute. Retrieved 17 February 2014.
- ↑ "Dmitry I. Gabrilovich, M.D., Ph.D." The Wistar Institute. Retrieved 17 February 2014.
- ↑ "Speaker Biography: Dmitry Gabrilovich". Immunopharmacology. Retrieved 17 February 2014.
- ↑ "Impediment to some cancer immunotherapy involves the free radical peroxynitrite". Science Daily. Retrieved 17 February 2014.
- ↑ "Cancer-specific myelopoiesis". Nature Asia. Retrieved 17 February 2014.
- ↑ "Speaker Biography: Dmitry Gabrilovich". Immunopharmacology. Retrieved 17 February 2014.
External links[edit | edit source]
   | This biographical article related to medicine in the United States is a stub. You can help WikiMD by expanding it. |
 | This oncology article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
